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Abstract
Background: The evaluation of abstracts for scientific meetings has been shown to suffer from
poor inter observer reliability. A measure was developed to assess the formal quality of abstract
submissions in a standardized way.
Methods: Item selection was based on scoring systems for full reports, taking into account
published guidelines for structured abstracts. Interrater agreement was examined using a random
sample of submissions to the American Gastroenterological Association, stratified for research
type (n = 100, 1992–1995). For construct validity, the association of formal quality with acceptance
for presentation was examined. A questionnaire to expert reviewers evaluated sensibility items,
such as ease of use and comprehensiveness.
Results: The index comprised 19 items. The summary quality scores showed good interrater
agreement (intra class coefficient 0.60 – 0.81). Good abstract quality was associated with abstract
acceptance for presentation at the meeting. The instrument was found to be acceptable by expert
reviewers.
Conclusion: A quality index was developed for the evaluation of scientific meeting abstracts which
was shown to be reliable, valid and useful.
Background
The presentation of research at scientific meetings is an es-
sential part of scientific communication. The choice of
which research will be presented at a meeting is usually
based on peer-review of abstracts submitted by interested
investigators. Only about 50% of the research projects in-
itially submitted as conference abstracts will eventually be
published as full articles in peer-reviewed journals and
full publication may not occur for several years [1,2]. As a
result, a published abstract from a scientific meeting is of-
ten the only permanent source of information available
on the methodology and results of a research project.
When writing an abstract, investigators are limited on the
amount of detail on the study's methodology and results
that they can include. This may partly explain the poor ob-
server-agreement and several kinds of bias that have been
demonstrated in the abstract selection procedures for var-
ious medical specialty meetings [3–9]. However, there is
evidence that the quality of the presentation of informa-
tion in an abstract is associated with the scientific quality
of the research [10]. Therefore, standardized methods for
assessing formal abstract quality may help improve the re-
liability of abstract selection and, if used as a checklist, re-
sult in more informative and useful abstracts.
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published for use with full reports of clinical research
[11,12]. No such score is available for the evaluation of
abstracts. Also, there is little information addressing the
reporting of the methodology and results in basic science
research. The objective of this study was to develop a reli-
able instrument to assess the quality of meeting abstracts
that would be applicable to a wide variety of research
types, including both clinical and basic science.
Methods
Material
We used abstracts submitted to the 1992 to 1995 annual
meetings of the American Gastroenterological Association
(AGA) to develop and test a quality scoring instrument for
abstracts. Each year several thousands of abstracts on all
aspects of research in gastroenterology are submitted to
this meeting. All submitted abstracts were published in a
yearly supplement to the journal Gastroenterology whether
or not they were accepted for presentation at the meeting.
Abstracts selected for oral or poster presentation were
marked, however, the mode of presentation was not spec-
ified. Abstracts were submitted on a standard form that
limited the length to between 200 to 350 words, depend-
ing on font size and inclusion of graphs. A structured for-
mat (Background & Aims, Methods, Results, Conclusion)
was not mandatory but was commonly used.
For the purpose of this study, we divided the abstracts into
different research types. Basic science studies (BSS) com-
prise all studies, done in a laboratory setting, where the
unit of analysis was not an intact human. Controlled clin-
ical trials (CCT) included prospective studies on the ef-
fects of diagnostic tests or therapeutic interventions, using
parallel or cross over controls. All other studies using hu-
mans were categorized as "other clinical research" (OCR)
and included human physiology experiments, epidemio-
logical studies and uncontrolled therapeutic studies.
A large sample (n = 1000) was selected for use in a follow
up study on publication bias using computer generated
random numbers based on a database containing all ab-
stracts submitted (17 205). This sampling was stratified by
research type to increase the proportion of RCT's. For the
test development and testing, a random subsample (n =
100) was collected from this sample. The eventual sample
included 42 CCT's, 39 OCR, and 19 BSS. The abstracts
were assessed in a prespecified order.
Item generation and reduction
Formal abstract quality was conceptualized as the combi-
nation of the methodological strength of the research as
well as the clarity of the presentation. The methodological
strength of the research included those methods used to
improve the internal validity of the study as reported in
the abstract.
Item selection and instrument structure were based on
previously published instruments used to assess the qual-
ity of full manuscripts in therapeutic trials and epidemio-
logical research [11,13–15]. A measure developed by Cho
and Bero was particularly influential because of its appli-
cability to different types of clinical research [16]. We
could not identify any work on quality scoring in basic sci-
ence reports.
When adapting this scale for use with abstracts, we took
into account published guidelines for the composition of
structured abstracts for original research for publication in
biomedical journals [17,18]. Similar guidelines for meet-
ing abstracts and basic science reports had not been pub-
lished. For content validity, the list of items was discussed
face to face and repeatedly with one researcher each in lab
based medicine (J. Wallace, Calgary), health care research
(RJ Hilsden), and clinical trials (LR Sutherland). The in-
strument was further modified following a pilot study of
80 abstracts that were scored by two raters and subse-
quently discussed in detail. Items were simplified or
dropped if consensus decisions were difficult or if suffi-
cient information was absent in the majority of abstracts,
unless the item was considered essential for the evalua-
tion of study validity by at least one of the reviewers. Input
on the final instrument was sought from researchers in the
three fields from across Canada by sending them the in-
strument and a questionnaire on the appropriateness of
the items included (Table 2). No further items were sug-
gested to be added or dropped by those surveyed.
The resulting instrument allowed for the calculation of a
summary score with a range from 0 to 1. Summary scores
are reported as mean scores with standard errors of the
mean (SEM).
Interrater and test-retest reliability
We tested interrater reliability on 100 abstracts scored by
two raters with training in gastroenterology and epidemi-
ology (AT and RJH). Test-retest reliability was determined
through the duplicate scoring of 85 abstracts by the same
observer (AT) with an interval of four to six weeks. The
raters were blinded to name and institution of the authors
and to whether the abstract had been selected for presen-
tation. For each item, the kappa coefficient was used to as-
sess the degree of agreement beyond what might be
expected by chance [19]. A kappa score in the range of
0.41 to 0.60 was considered to represent moderate agree-
ment, and a kappa score in the range of 0.61 to 0.80 was
considered substantial agreement [20]. Agreement be-
tween summary scores was assessed using the intra class
correlation coefficient [21]. This measure is the ratio ofPage 2 of 7
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close to 1 is found when the variance is almost exclusively
due to differences between the abstracts, while low ratios
represent a strong influence of random error and/or ob-
server variance on the overall variance. There is no univer-
sally accepted cut off of Ri for good agreement, as it is
appreciated that this depends on the number of subjects
studied and the context in which the decisions based on
the instrument will be made [21]. For this study, moder-
ate agreement was defined as Ri > 0.6 and good agreement
as Ri > 0.8.
Construct validity
To examine construct validity, we hypothesized that high-
er abstract quality scores should correlate with abstract ac-
ceptance by the AGA. To test this hypothesis, the mean
quality scores of rejected and accepted abstracts were com-
pared using Student t-tests for independent samples.
Sensibility
The sensibility of an instrument, as defined by Feinstein,
comprises different aspects of usability, such as compre-
hensibility, ease of use, face and content validity, and suit-
ability for the purpose at hand [22]. A sensibility
questionnaire was adapted from Oxman [23,24] to assess
the usefulness of the newly developed score (see appen-
dix). This questionnaire was sent to 24 Canadian research-
ers in gastroenterology and epidemiology. The researchers
rated each item based on a seven-point scale (1= unac-
ceptable, 7 = criterion fully met). We considered a mean
rating of >5 to indicate general satisfaction with and ac-
ceptability of an item.
Results
The review of the literature and expert opinion resulted in
the generation of 24 quality assessment items pertaining
to the study purpose, methods, reporting of results and
conclusions. Following the pilot-study, the instrument
was reduced to 19 items. Two items on research methods
were discarded because they were never applicable to the
abstracts evaluated (1. whether random selection from the
study population was performed; 2. if yes, which method
of random selection was used). A priori sample size con-
siderations were also never reported. Instead, for use in
abstracts, the reporting of posteriori sample size considera-
tions or power calculations for negative results was con-
sidered sufficient. Two pairs of items were combined into
single items. First, "control for confounding by the study
design" and "control for confounding by the analysis"
were combined into "confounding controlled for?". Sec-
ond, because it was too difficult to discern between the in-
clusion/exclusion criteria and the baseline characteristics
of the subjects, it was considered sufficient if either were
included in the abstract. Although the method of rand-
omization in randomized trials was never described, an
item on this was retained because it was considered essen-
tial for the assessment of study quality. Following the pi-
lot testing, several items were reworded for simplification
and clarity. A detailed manual was written that provided
the definitions used for each item (manual available from
the authors). Using the instrument and manual, the aver-
age time required to score an abstract was 3:45 minutes
(range 2:30 to 6:00 minutes). The final 19-item instru-
ment is shown in the appendix.
Reliability
For the 100 abstracts independently assessed by two
raters, quality scores ranged from 0.28 to 0.95, and were
approximately normally distributed. As shown in table 1,
the inter-observer agreement was highest for controlled
clinical trials and lowest for basic science abstracts. Indi-
vidual item analysis showed substantial agreement for the
description of random allocation, investigator and subject
blinding, appropriateness of sample size, reporting of at-
trition, and reporting of statistical tests. Moderate agree-
ment was achieved for the appropriateness of the controls
and the appropriateness of the statistical methods. The
agreement was low for the remaining items (description
of study objective, description and appropriateness of the
design, method of subject selection, definition of out-
come measure, control for confounding, exact p-values or
confidence intervals, reporting of results, and conclusions
supported by the results).
Test-retest reliability was good independent of the re-
search type, with identical mean scores for first and sec-
ond evaluations (0.57) and an intra-class coefficient of
0.85. Individual items also had good test-retest reliability
(range of kappa coefficients, 0.54 to 0.85).
Table 1: Interrater reliability.
Type of research n mean summary score observer 
1 (SEM)
mean summary score observer 
2 (SEM)
intra class correlation 
coefficient (Ri)
Clinical trials only 42 .63 (.02) .63 (.02) .81
Other clinical research 39 .57 (.02) .59 (.02) .67
Basic science 19 .50 (.02) .61 (.03) .60
SEM = standard error of the meanPage 3 of 7
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In total, 67 of the 100 abstracts were accepted for presen-
tation at the AGA meeting. These abstracts had significant-
ly higher quality scores compared with the rejected
abstracts (0.61 vs. 0.54, p = 0.001). The quality scores
were higher for accepted abstracts compared with rejected
abstracts for all research types, but this was only statistical-
ly significant for clinical trials (n = 42, 0.67 vs. 0.52, p <
0.001).
Sensibility
Sensibility ratings were available from 15 reviewers (sur-
vey response rate 62.5%). As shown in Table 2, clinical
and health care researchers found the instrument useful
and acceptable for the purpose described. The reviewers
felt that both the research methodology and quality of the
report were adequately assessed by our instrument (Table
2). In general, basic scientists found the instrument less
useful, largely because of the time and effort required.
Both groups of reviewers considered the applicability to
basic science abstracts to be a problem. The issue of the
limited amount of information available from abstracts
was also raised.
Discussion
We have developed a reliable instrument for assessing the
quality of an abstract submitted to a scientific meeting.
The instrument rates both the quality of the reporting and
the quality of the research methods. While a variety of
scales are available for the assessment of full reports of
clinical trials, abstract evaluation has usually involved in-
formal ad hoc scales or checklists [4,18,25,26] or has been
restricted to the quality of reporting only [18,27,28]. Fur-
thermore, most abstract evaluation studies were based on
summaries of published research.
The limited amount of information available from ab-
stracts was the greatest challenge in the development of
this instrument. The methodological quality of research
can only be assessed to the extent that pertinent informa-
tion is available in the report. There is controversy over
how well the quality of research is reflected in a short re-
port [25,29,30]. Furthermore, the quality of the report
and the quality of the research are often intertwined. The
experts in our sensibility survey felt that our instrument
adequately assessed both the research methodology and
the quality of the report. However, we appreciate that the
lack of a clear distinction between these two concepts of
quality in our instrument may be unsatisfactory to some
users, as may the restriction to formal aspects of scientific
quality. Our instrument avoids any judgment of content,
such as, originality, ethics or scientific relevance. It is rec-
ommended that these factors be assessed separately, as
suggested by other authors [16,28,31]. However, there is
evidence that the formal quality of a research report
reflects the content or overall quality of the research
[28,32]. This view is supported by the association of high-
er quality scores with abstract acceptance by the AGA.
A few important items seem to be missing in our instru-
ment. These are characteristics which were never reported
in any of the abstracts, although they have been shown to
be essential to the validity of study results. Most promi-
nently, this concerns concealment of allocation in RCT's.
Table 2: Sensibility ratings
Basic Scientists (range) Clinical & Health Care Researchers
Number of reviewers 4 11
1. Wide applicability 3.5 (1–5) 5.7 (3–7)
2. Use in basic science 2.5 (1–5) 5.4 (4–7)
3. Use in clinical research 4.5 (1–6) 5.8 (4–7)
4. Clarity and simplicity 3.3 (1–5) 5.7 (5–7)
5. Time and effort needed 2.3 (1–5) 5.6 (5–7)
6. Adequate instructions 3.8 (1–5) 5.8 (5–7)
7. Information available from abstract 4.0 (3–5) 4.6 (4–5)
8. Need for subjective decisions 4.8 (3–6) 5.4 (4–7)
9. No redundancy 4.3 (3–5) 6.3 (5–7)
10. Comprehensiveness 5.5 (2–7) 5.9 (3–7)
11. Response options 6.0 (4–7) 5.9 (3–7)
12. Discriminative power 5.8 (5–7) 5.7 (5–7)
13. Measures methodology 5.5 (4–7) 5.7 (4–7)
14. Measures reporting 5.3 (3–7) 5.9 (5–7)
Mean rating 4.3 (3.3–5.7) 5.7 (4.9–6.5)
Ratings on a scale from 1 (unacceptable) to 7 (fully met). Mean > 5: item acceptablePage 4 of 7
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by abstract authors because the paper by Schulz, demon-
strating the bias introduced by open allocation was only
published in 1995, i.e. after conclusion of our abstract
submission period studied [33].
Generally, the use of summary scores should be viewed
with caution. In the context of meta-analysis, the individ-
ual assessment of the various methodological aspects has
been shown to be more informative with respect to their
effect on effect size. The excellent meta-analysis by Jüni et
al. on quality scoring of clinical trials was not published
when we developed our instrument [12]. In contrast, the
use of a summary score rather than components is more
helpful if a range of diverse designs and topics is evaluat-
ed, as the number of shared components is rare.
One of the objections raised in the sensibility survey was
the time and effort needed to complete a checklist of 19
items. It is appreciated that this list may seem daunting,
especially as previous instruments on full reports were re-
stricted to as few as three items. However, instruments
such as the checklist used by Chalmers, the Delphi list, or
the short instrument by Jadad were developed to assess
full reports of randomized clinical trials in the context of
meta-analysis [13,14,34]. This entails the possibility (in
some cases: necessity) to tailor the instrument to the study
subject at hand. In contrast, it was our aim to develop an
instrument that would be applicable to a wider variety of
research types and subjects. Furthermore, even for rand-
omized controlled trials, the use of a three item score was
shown to be not useful in the evaluation of abstract qual-
ity in a follow up study on scientific abstracts by I. Chalm-
ers [26]. This may be due to insufficient information
provided in abstracts. A more sensitive instrument is
needed for abstracts. Also, other items are required for the
evaluation of other types of research, such as adequate
control for confounding in observational studies. Conse-
quently, depending on the study design, only a limited
number of items are applicable for each individual ab-
stract. The average time of less than 4 minutes per abstract
seemed a reasonable effort. However, this time does not
include an evaluation of the scientific background of the
study question nor the appreciation of the importance of
its conclusions for the scientific community.
Problems were encountered when we tried to tailor the in-
strument to basic science research reports. In fact, the re-
sults of both the reliability testing and the sensibility
survey indicate that the instrument may be less suitable
for this type of research. We are not aware of any literature
on the formal assessment of quality in the design and re-
porting of basic science research. Therefore, some of the
problems encountered were due to a lack of generally
agreed upon criteria for the evaluation of this type of re-
search. However, the main difficulty when reading basic
science abstracts related to the omission of basic informa-
tion such as the formulation of the research objective and
clarification of the research design. Lower quality scores,
an increased need for subjective judgments because of
limited information, and lack of scale acceptance by basic
science reviewers may be interrelated and may reflect, in
general, a lesser interest in structured reporting in basic
science abstracts.
The score was subsequently successfully used in a study
examining the determinants of abstract acceptance and
publication in gastroenterological research [35,36]. High
abstract quality scores were associated with higher chanc-
es for acceptance for presentation at a meeting, and were
also associated with higher impact factors, if abstracts
were followed by full publications.
Conclusions
In summary, we have developed a reliable, valid and ap-
plicable instrument for the evaluation of the quality of sci-
entific abstracts. While most useful in the clinical research
setting, particularly for clinical trials, limitations may ap-
ply for its use in basic science. It may also be helpful as a
checklist for the preparation of scientific abstracts or serve
as an instrument to compare abstract quality between
meetings or over time. Other possible applications in-
clude the adjunct use in abstract peer review. More work
is needed to improve the instrument for use in basic sci-
ence research and to assess the applicability to other med-
ical specialties. Also, further research should test the
hypothesis that this instrument will reduce bias in the se-




A. Timmer and RJ Hilsden developed the instrument,
evaluated abstracts and jointly wrote the manuscript. The
statistical analyses were performed by A. Timmer. LR
Sutherland conceived and supervised the study, and con-
tributed to the instrument modifications and to the writ-
ing of the manuscript.
Tables and Appendix
Tables and appendices are added at the end of the manu-
script as follows:
Table 1: Interrater reliability
Table 2: Sensibility ratings
Appendix A: Quality scoring instrument (see additional
file 1)Page 5 of 7
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(see additional file 2)
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